DCX and neoplasm: Both CD8+ and CD4+ T cells play important effector roles in anti-tumor immunity [21], and investigators interested in querying antigen-specific responses in pools containing both CD8+ and CD4+ T cells should consider inclusion of Signal F and DC-LAMP in mRNA expression constructs.